PT Siloam International Hospitals Tbk (FRA:2LS) 3-Year ROIIC % : 8.77% (As of Dec. 2025) — 12% Above Median


FRA:2LS PT Siloam International Hospitals Tbk FRA:2LS
69 GF Score
Price €0.10
GF Value €0.13
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is PT Siloam International Hospitals Tbk 3-Year ROIIC %?

PT Siloam International Hospitals Tbk FRA:2LS -0.98% 69 3-Year ROIIC % is 8.77 as of Dec. 2025, which is 12% above its 10-year median of 7.85. GuruFocus rates FRA:2LS with a GF Score™ of 69/100 and a GF Value™ of €0.13 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 618 Healthcare Providers & Services companies, PT Siloam International Hospitals Tbk ranks better than 61% on this metric.

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. PT Siloam International Hospitals Tbk's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 8.77%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for PT Siloam International Hospitals Tbk's 3-Year ROIIC % or its related term are showing as below:

FRA:2LS's 3-Year ROIIC % is ranked better than
61% of 618 companies
in the Healthcare Providers & Services industry
Industry Median: 3.145 vs FRA:2LS: 8.77

PT Siloam International Hospitals Tbk  (FRA:2LS) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


PT Siloam International Hospitals Tbk 3-Year ROIIC % Related Terms


PT Siloam International Hospitals Tbk 3-Year ROIIC % Historical Data

* Premium members only.

The historical data trend for PT Siloam International Hospitals Tbk's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Siloam International Hospitals Tbk 3-Year ROIIC % Chart

PT Siloam International Hospitals Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 340.33 33.65 45.66 6.93 8.77

PT Siloam International Hospitals Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 8.77 0.00

FRA:2LS vs HCA, THC, DVA: 3-Year ROIIC % Comparison

For the Medical Care Facilities subindustry, PT Siloam International Hospitals Tbk's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Siloam International Hospitals Tbk 3-Year ROIIC % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Siloam International Hospitals Tbk's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where PT Siloam International Hospitals Tbk's 3-Year ROIIC % falls into.


FRA:2LS
69GF Score
PT Siloam International Hospitals Tbk FRA:2LS
3-Year ROIIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Siloam International Hospitals Tbk 3-Year ROIIC % Calculation

PT Siloam International Hospitals Tbk's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( 67.441264 (Dec. 2025) - 48.6036082 (Dec. 2022) )/( 733.924 (Dec. 2025) - 512.547 (Dec. 2022) )
=18.8376558/221.377
=8.51%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Frequently Asked Questions Learn more about 3-Year ROIIC % →
What does a 3-Year ROIIC % of 8.77 mean?
PT Siloam International Hospitals Tbk (FRA:2LS) has a 3-Year ROIIC % of 8.77 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on PT Siloam International Hospitals Tbk and its competitors. This is 12% above median its historical median of 7.85. According to the industry distribution chart, PT Siloam International Hospitals Tbk ranks #241 out of 618 companies in the Healthcare Providers & Services industry, placing it in the top 39%.
Is PT Siloam International Hospitals Tbk's 3-Year ROIIC % too high?
PT Siloam International Hospitals Tbk's current 3-Year ROIIC % of 8.77 is 12% above median its 10-year median of 7.85. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.15. PT Siloam International Hospitals Tbk's value of 8.77 is 178.9% above this industry median. Based on the distribution chart, PT Siloam International Hospitals Tbk ranks #241 out of 618 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PT Siloam International Hospitals Tbk has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Siloam International Hospitals Tbk's 3-Year ROIIC % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Siloam International Hospitals Tbk ranks #241 out of 618 companies for 3-Year ROIIC %. This puts PT Siloam International Hospitals Tbk in the upper half of its industry. The industry median 3-Year ROIIC % is 3.15. PT Siloam International Hospitals Tbk's value of 8.77 is 178.9% above this benchmark. While the company's 10-year median is 7.85 vs. the industry median of 3.15, PT Siloam International Hospitals Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.15, based on 618 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Siloam International Hospitals Tbk's current 3-Year ROIIC % of 8.77 is 178.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on PT Siloam International Hospitals Tbk and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Siloam International Hospitals Tbk's current 3-Year ROIIC % is 8.77, which is 12% above median its own 10-year median of 7.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Siloam International Hospitals Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk (FRA:2LS) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.13, compared to a current price of €0.10 — trading 22.3% below its estimated fair value. The current 3-Year ROIIC % is 8.77, which is 12% above median its 10-year median of 7.85 and 178.9% above the Healthcare Providers & Services industry median of 3.15. PT Siloam International Hospitals Tbk's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For PT Siloam International Hospitals Tbk (FRA:2LS), the current 3-Year ROIIC % is 8.77 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Siloam International Hospitals Tbk (FRA:2LS) Overvalued in 2026?

Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk stock appears to be undervalued. The current stock price of €0.10 is trading 22.3% below its estimated GF Value™ of €0.13. GuruFocus considers PT Siloam International Hospitals Tbk to be Modestly Undervalued.

Key valuation signals for FRA:2LS:

  • 3-Year ROIIC %: 8.77 (12% above median its 10-year median of 7.85)
  • GF Value™: €0.13 vs. price of €0.10 (22.3% below fair value)
  • GF Score™: 69/100 with 2 warning signs
  • Industry Position: 178.9% above the Healthcare Providers & Services median (#241 of 618)

No single metric tells the full story. See the FRA:2LS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Siloam International Hospitals Tbk Business Description

Other Exchanges SILO:Indonesia
Address No. 15, Jalan Boulevard Sudirman, Floor 32, Gedung Fakultas Kedokteran Universitas Pelita Harapan, Lippo Village, Tangerang, IDN, 15810
PT Siloam International Hospitals Tbk operates a network of hospitals in Indonesia. Its hospitals are located in the Greater Jakarta area and across Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara, Ambon, and other areas across Indonesia, along with several Siloam Clinics. The company offers an integrated, one-stop care ecosystem designed to provide comprehensive healthcare services, spanning examination, diagnosis, clinical management, rehabilitation, and health education. Additionally, it offers special clinical services in the following segments, including neurosciences, neurology, digestive, cardiac, orthopedic, etc., by running the Center of Excellence and specialty centers. The company generates the majority of its revenue by offering hospitalization and outpatient services.
69GF Score

Get the complete analysis for FRA:2LS

3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.13
GF Value